Release date: 2024-08-23 17:45:57 Article From: Lucius Laos Recommended: 117
As a PIK3CA inhibitor, Alpelisib works synergistically with fulvestrant to significantly improve the prognosis of breast cancer patients with HR/HER2- and PIK3CA mutations.
According to the latest market survey, the latest prices and versions of Alpelisib in 2024 are sorted out below. The price of Laos Lucius version of Alpelisib (150mg*28 tablets) is about 1755 yuan.
The India export version offers a combination of 200mg*14 capsules and 150mg*28 capsules, and the price is about 3900 yuan. The price of the Hong Kong export version of 150mg*56 capsules is higher, about 43,800 yuan. These price differences may be related to factors such as production location, specifications, and market demand.
Knowing the market price of the different versions, we will move on to the interaction of Apelix with other drugs.
Understanding the interactions of apellix with other drugs is essential to avoid potential drug conflicts.
Concomitant use with strong CYP3A4 inducers may reduce the concentration of apellix and reduce the efficacy of the drug. Concomitant use of strong CYP3A4 inducers should be avoided and alternative agents with minimal effect on CYP3A4 induction should be considered.
Concomitant use with BCRP inhibitors may increase the concentration of apellix and increase the risk of toxicity. If alternative drugs are not available, close monitoring for possible adverse effects is required.
Understanding the interactions of apelix with other drugs allows for better management of treatment options. Next, we will explore the use of Apelix in special populations.
When using Alpelisib in different populations, special attention needs to be paid to adaptability and potential risks.
Before using Apellix, it is necessary to confirm that the woman is pregnant. Women should use effective contraception during treatment and for a week after taking the drug. Male partners should also use contraception. Animal studies have shown that this drug may affect fertility.
The safety and efficacy of apellix in children has not been established.
Understanding the dos and don'ts of medication in special populations allows for better adjustment of treatment options to meet individual needs. If you have any doubts or discomfort, consult your doctor promptly.
[Warm tips] When using Apelix, please adjust the medication regimen according to your personal situation and your doctor's recommendations. If you experience any problems or discomfort, please contact a medical professional promptly.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: